Myocardial growth and hypertrophy are characterized by coordinate increases in myofibrillar protein content. The long term objective of this proposal is to delineate the molecular mechanisms which couple the hypertrophic stimulus with the accumulation of myofibrillar protein. Recent evidence obtained from skeletal muscle suggests that myofibrillar protein content and composition can be controlled at the level of myofibrillar gene expression; i.e., the transcription of mRNAs from the corresponding myofibrillar genes. The central hypothesis to be tested in this proposal is that the increase in myofibrillar protein content during cardiac growth and hypertrophy is due to an increase in the level of mRNAs which code for specific myofibrillar proteins. It is postulated that the level of a specific myofibrillar mRNA species is regulated by the rate of transcription from the corresponding myofibrillar gene(s). Thus, coordinate regulation of myofibrillar protein synthesis during cardiac growth and hypertrophy may be mediated by coordinate increases in myofibrillar gene transcription. In addition, we hypothesize that hydrolysis of phosphatidylinositol and/or the activation of protein kinase C may play a role in the generation and/or transmission of the hypertrophic response of cardiac muscle cells. Accordingly, the Specific Aims of this proposal are five fold: 1) to examine the correlation between changes in the level of an individual myofibrillar protein in a cultured cell model of myocardial growth and hypertrophy; 2) to determine if there is an increase in the rate of transcription of an individual myofibrillar gene and/or an increase in myofibrillar mRNA stability in a cultured myocardial cell model of growth and hypertrophy; 3) to determine if the rate of transcription of two separate myofibrillar genes is coordinately regulated in this model; 4) to determine if the rate of transcription of a non-myofibrillar gene is coordinately regulated with the transcription of myofibrillar genes in this cell model of cardiac mypertrophy; 5) to determine if the hydrolysis of phosphatidylinositol and/or the activation of protein kinase C are involved in coupling the hypertrophic stimulus to the increase in myofibrillar protein synthesis and associated alterations in myofibrillar gene expression.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL036139-01A1
Application #
3350836
Study Section
Molecular Cytology Study Section (CTY)
Project Start
1986-12-01
Project End
1989-11-30
Budget Start
1986-12-01
Budget End
1987-11-30
Support Year
1
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Type
Overall Medical
DUNS #
City
Dallas
State
TX
Country
United States
Zip Code
75390
Harris, A N; Ruiz-Lozano, P; Chen, Y F et al. (1997) A novel A/T-rich element mediates ANF gene expression during cardiac myocyte hypertrophy. J Mol Cell Cardiol 29:515-25
Lembo, G; Rockman, H A; Hunter, J J et al. (1996) Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest 98:2648-55
Hunter, J J; Tanaka, N; Rockman, H A et al. (1995) Ventricular expression of a MLC-2v-ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270:23173-8
Dyson, E; Sucov, H M; Kubalak, S W et al. (1995) Atrial-like phenotype is associated with embryonic ventricular failure in retinoid X receptor alpha -/- mice. Proc Natl Acad Sci U S A 92:7386-90
Navankasattusas, S; Sawadogo, M; van Bilsen, M et al. (1994) The basic helix-loop-helix protein upstream stimulating factor regulates the cardiac ventricular myosin light-chain 2 gene via independent cis regulatory elements. Mol Cell Biol 14:7331-9
Lee, K J; Hickey, R; Zhu, H et al. (1994) Positive regulatory elements (HF-1a and HF-1b) and a novel negative regulatory element (HF-3) mediate ventricular muscle-specific expression of myosin light-chain 2-luciferase fusion genes in transgenic mice. Mol Cell Biol 14:1220-9
Kubalak, S W; Miller-Hance, W C; O'Brien, T X et al. (1994) Chamber specification of atrial myosin light chain-2 expression precedes septation during murine cardiogenesis. J Biol Chem 269:16961-70
Chien, K R; Zhu, H; Knowlton, K U et al. (1993) Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 55:77-95
Zhu, H; Nguyen, V T; Brown, A B et al. (1993) A novel, tissue-restricted zinc finger protein (HF-1b) binds to the cardiac regulatory element (HF-1b/MEF-2) in the rat myosin light-chain 2 gene. Mol Cell Biol 13:4432-44
Miller-Hance, W C; LaCorbiere, M; Fuller, S J et al. (1993) In vitro chamber specification during embryonic stem cell cardiogenesis. Expression of the ventricular myosin light chain-2 gene is independent of heart tube formation. J Biol Chem 268:25244-52

Showing the most recent 10 out of 22 publications